Bromocriptine efficacy varies due to genetic polymorphisms in dopamine receptor genes. Genetic testing can identify these variances, enabling tailored dosing for optimal response.

Genetic variations in the cytochrome P450 enzymes affect bromocriptine metabolism. Testing these genes helps adjust drug doses to reduce side effects and improve efficacy.

Certain genes affect neurotransmitter pathways that interact with bromocriptine. By analyzing these genes, clinicians can predict therapy outcomes, customizing treatment plans for better results.